Cargando…
PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca(2+) regulation
Post‐menopausal women have a higher risk of developing cardiometabolic dysfunction. Atorvastatin attenuates dyslipidaemia and cardiac dysfunction but it can have undesirable effects including increased risk of diabetes and myalgia. Currently, the proprotein convertase subtilisin/kexin type 9 (PCSK9)...
Autores principales: | Amput, Patchareeya, Palee, Siripong, Arunsak, Busarin, Pratchayasakul, Wasana, Thonusin, Chanisa, Kerdphoo, Sasiwan, Jaiwongkam, Thidarat, Chattipakorn, Siriporn C., Chattipakorn, Nipon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417720/ https://www.ncbi.nlm.nih.gov/pubmed/32628813 http://dx.doi.org/10.1111/jcmm.15556 |
Ejemplares similares
-
High Cardiorespiratory Fitness Protects against Molecular Impairments of Metabolism, Heart, and Brain with Higher Efficacy in Obesity-Induced Premature Aging
por: Pantiya, Patcharapong, et al.
Publicado: (2022) -
PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
por: Palee, Siripong, et al.
Publicado: (2019) -
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
por: Lahnwong, Sarayut, et al.
Publicado: (2020) -
Hyperbaric oxygen therapy effectively alleviates D-galactose-induced-age-related cardiac dysfunction via attenuating mitochondrial dysfunction in pre-diabetic rats
por: Bo-Htay, Cherry, et al.
Publicado: (2021) -
D-galactose-induced aging aggravates obesity-induced bone dyshomeostasis
por: Imerb, Napatsorn, et al.
Publicado: (2022)